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ABSTRACT 
We have compared the expression of atria1 natriuretic peptide (ANP) 
and brain natriuretic peptide (BNP) genes in various human tissues 
using a quantitative polymerase chain reaction technique. Tissues of 
three human subjects, obtained at autopsy, were analyzed. BNP tran- 
scripts could be detected in the central nervous system, lung, thyroid, 
adrenal, kidney, spleen, small intestine, ovary, uterus, and striated 
muscle. ANP transcripts could also be demonstrated in various human 
extracardiac tissues including several endocrine organs. In all periph- 
era1 tissues, the level of both natriuretic peptide transcripts was ap- 
proximately l-2 orders of magnitude lower than in cardiac ventricular 
tissues. This distribution is in marked contrast to the much lower level 
of ANP and BNP transcripts present in extracardiac rat tissues (gen- 
erally less than l/1000 of ventricles). These data suggest differential 
expression of the two natriuretic peptide genes in cardiac and extra- 
cardiac tissues in man. Furthermore, the presence of local synthesis of 
ANP and BNP in various peripheral organs su gests paracrine and/or 
autocrine function of these natriuretic pepti es. (J Clin Endocrinol 2 
Metab 78:1307-1311,1994) 
T HE CARDIAC hormones atria1 natriuretic peptide (ANP) and brain natriuretic peptide (BNP) exhibit similar phar- 
macological profiles, such as natriuresis and smooth muscle 
relaxation (1). Along with these common properties there are 
striking dissimilarities: Whereas the structure of ANP is 
highly conserved among different species, there is consider- 
able variation of the amino acid sequence of BNP. Further- 
more, there are differences regarding their tissue distribution. 
The heart is the major site of synthesis of ANP, but low 
levels of ANP transcription have also been found in various 
other tissues of different species (2-13), including human 
where ANP messenger RNA (mRNA) has been detected in 
heart (2) and thymus (12). Although originally identified and 
isolated from the porcine brain (14) BNP has been shown to 
be mainly a cardiac hormone; in fact, all BNP complimentary 
DNA (cDNAs), porcine (15, 16), rat (17), and human (18) 
were isolated from cardiac cDNA libraries. Tissue distribution 
of BNP has been studied in rat at the peptide (19-21) and 
mRNA (22) levels. In human, BNP peptide was described in 
atria and ventricles (23-25) and more recently in brain (26). 
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The presence of BNP immunoreactivity in human (26) and 
porcine (14) but not rat (19, 21) brain raises the question of 
species specific distribution of the peptide. Therefore we 
undertook the analysis of ANP and BNP gene expression in 
extracardiac human tissues using quantitative PCR amplifi- 
cation of human ANP and BNP transcripts, 
Subjects and Methods 
Tissues 
Human tissues were obtained from three subjects at autopsy. 
Subjects 
Subject A: female, 57 yr, with metastatic ovarian carcinoma (heart 
weight: 310 g); subject B: male, 57 yr, suffered from cardiac hypertrophy 
(heart weight: 640 g) and died of cardiac arrest; subject C: female, 33 
yr, suffered cardiogenic shock after coronary artery dissection (heart 
weight: 340 g). Tissue samples were frozen in liquid nitrogen and 
maintained at -80° C until RNA extraction. 
RNA extraction. Total RNA was extracted by the guanidinium thiocya- 
nide method (27). The integrity of RNA preparations was assessed by 
electrophoresis on agarose gels; RNA samples were quantified by meas- 
uring UV absorbance at 260 nm and by dot blot hybridization to end- 
labeled p(dt)lz-ls. 
cDNA synthesis. Samples of 2 rg total RNA were mixed with 2 rg 
p(dT)i2-i8 (Sigma, St. Louis, MO), fifteen units of avian myeloblastosis 
virus transcriptase (Promega, Madison, WI) and 34 U RNA inhibitor 
(Pharmacia, Piscataway, NJ), as described previously (22). After incu- 
bation at 37O C for 1.5 h cDNA samples were used directly for polym- 
erase chain reaction (PCR) amplification. 
PCR amplification of ANP and BNP transcripts. The sense and antisense 
primers used to amplify ANP (sense primer 5’-CTTGACGACGCCAG 
CATGAGC, antisense primer 5’.TCCGCTCTGGGCTCCAATCCT) 
and BNP (sense primer 5’-TTCCTGGGAGGTCGTTCCCAC, antisense 
primer 5’-CATCTTCCTCCCAAAGCAGCC) templates corresponded 
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to sequences in the first and second exons of the respective genes (28, 
29). The amplification of ANP and BNP was carried out using various 
amounts from the same preparations of cDNA. 
cDNA was subjected to 22-25 cycles of PCR amplification using 10 
U Vent polymerase (New England BioLabs, Beverly, MA). As an internal 
control for the amplification process, human genomic DNA was used; 
the principle of this quantitative PCR technique has been described in 
detail previously (30). Amplification of the cDNA and genomic DNA 
templates yielded 445 base pairs (bp) and 576 bp fragments for ANP 
and 291 bp and 522 bp fragments for BNP, respectively. Amplification 
products were separated by agarose gel electrophoresis and transferred 
to nylon membranes (Hybond, Amersham, UK). The DNA was then 
hybridized to end-labeled oligonucleotides (y-?‘-ATP 2000 rCi/mmol, 
T4-polynudeotide kinase) corresponding to sequences located between 
the two PCR primers in ANP (5’-GTCCATCCTGCCCCCGAAGCA- 
GCT) and BNP (5’-AGACCCTTGCACCATCTTGGGGC) genes, re- 
spectively. Quantification was performed by image analysis densitome- 
try of the hybridization bands. PCR experiments were performed using 
two cDNA preparations and conducted at least twice. 
Results 
Quantitative amplification of ANP and BNP sequences 
Optimal conditions for quantitative PCR require initial 
amounts of DNA template and numbers of PCR cycles 
yielding an exponential phase of amplification. Optimization 
of these conditions has been elaborated in detail previously 
(22, 30). Sixty nanograms of cardiac cDNA and 660 ng 
extracardiac cDNA with 425 ng genomic DNA and 22 cycles 
for cardiac and 85 ng genomic DNA and 25 cycles for 
extracardiac tissues were found to be in the linear range. 
With these amplification conditions, the yield of DNA prod- 
ucts was directly proportional to the initial amounts of tem- 
plate, both for ANP and BNP (Fig. 1, a, b). Coamplification 
of genomic DNA did not affect the yield of amplification 
products from cDNA templates as illustrated for amplifica- 
tion of BNP in cardiac cDNA (Fig. 2). 
ANP and BNP transcripts in various tissues 
Figure 3 demonstrates BNP expression in various extracar- 
disc tissues. ANP and BNP transcripts were quantified by 
calculating the relative abundance of the respective cDNA 
compared to the genomic DNA. Average atria1 abundance 
of ANP was 20- to SO-fold higher than ventricular abun- 
dance and both, ANP and BNP expression was clearly more 
abundant in ventricles than in the other tissues examined. 
Therefore extracardiac expression was compared to ventric- 
ular values. Abundance of transcripts in extracardiac tissues 
was at least one (subject A) or two (subject B) orders of 
magnitude lower than in ventricular tissue. Table 1 summa- 
rizes the expression of ANP and BNP found in various 
cardiac and extracardiac tissues of male and female subjects. 
In addition to the values shown for BNP and ANP in 
ventricles, BNP and ANP cDNA were quantitated in the 
ventricles of several controls (BNP: 20-45, ANP: 20-35 
cDNA/total DNA (% x 10e6) and several patients with 
cardiac hypertrophy (BNP: 200-600, ANP: 60-120 cDNA/ 
total DNA (% X 10m6). Thus, the levels of BNP and ANP in 
normal (subject A and C) and diseased (subject B) human 
ventricles are representative of a larger sample size. It was 
of interest to note that normal tissue of the ovary of female 
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FIG. 1. a, Amplification of BNP transcripts of atria1 (m) and ventric- 
ular (A) cDNA. Amplification products expressed as arbitrary OD units 
of densitometry of Southern blot are correlated with the number of 
PCR cycles. Exponential amplification is observed up to 25 cycles. b, 
Amplification of ANP transcripts of atria1 cDNA (A) and of BNP 
transcripts of genomic DNA (0). Amplification products expressed as 
arbitrary OD units of densitometry of Southern blot are correlated with 
the amount of DNA input. Linear relation of initial DNA and ampli- 
fication products is observed throughout. 
A (with ovarian carcinoma) showed the highest extracardiac 
expression of ANP and even more so, of BNP. Indeed, the 
levels of BNP transcripts were similar in ovaries and ventri- 
cles. This prompted us to analyze the level of BNP in non- 
diseased ovaries. Subject C with a normal ovary shows 
pituitary and lung BNP expression comparable to that of 
subject A (Table 2) but a 20-fold lower abundance of ovarian 
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FIG. 2. Amplification of BNP transcripts of increasing amounts of 
atria1 and ventricular cDNA. Coamplification with genomic DNA does 
not affect the yield of amplification products. 
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FIG. 3. BNP transcripts in various extracardiac human tissues of 
subject A (female, 57 yr) and subject B (male, 57 yr). cDNA was 
coamplitied with constant amounts of genomic DNA. The lower lane 
shows Southern blot of cDNA at longer exposure. Br, Brain; Pit, 
pituitary; Ut, uterus; Sp, spleen; Thy, thyroid; Ad, adrenal; Tes, testis; 
Pro, prostate; Int, small intestine. 
BNP transcripts than subject A. Thus, it appears that BNP 
transcripts are specifically increased in normal tissue of the 
ovaries of a patient with ovarian carcinoma. Comparing the 
expression of ANP and BNP, the most marked difference of 
abundance in subject A was observed in the kidney, exhib- 
iting more ANP than BNP transcripts. Consistent with pub- 
lished reports (25), subject B with cardiac hypertrophy 
showed stimulated levels of both ANP and BNP transcripts 
and a higher ratio of cardiac BNP/ANP. However, the in- 
crease in ventricular ANP and BNP transcripts was not 
accompanied by systematically elevated levels of ANP and 
BNP transcripts in extracardiac tissues where little if any 
variation was observed. Interestingly, there was much less 
ANP than BNP in testicular tissue. In fact, the ratio of BNP 
to ANP was variable in the different tissues examined sug- 
gesting differential expression of the two natriuretic peptide 
genes. Neither ANP nor BNP expression could be detected 
in liver or pancreas of any of the subjects investigated 
although tubulin transcripts were detected and served as 
control for the integrity of the RNA and cDNA preparations 
(data not shown). 
Discussion 
The family of natriuretic peptides includes, in addition to 
ANP, two other members, BNP and CNP (C-type natriuretic 
peptide). All three peptides share structural similarities and, 
in the case of ANP and BNP, bind with similar affinities to 
the same guanylate cyclase linked receptors (31). Recent 
studies, including our own, have shown that BNP and ANP 
are differentially expressed in heart atria and ventricles sug- 
gesting distinct functional roles for these two hormones (22, 
25). Despite its initial discovery in porcine brain about 5 yr 
ago, surprisingly little is known about BNP gene expression 
in extracardiac tissues. Indeed BNP transcripts have so far 
been detected in a very limited number of rat tissues, brain; 
lung; and aorta, at levels generally loo-fold lower than 
ventricles (22). This is in contrast to numerous reports which 
have documented the presence of ANP gene expression in 
several extracardiac tissues (reviewed in Refs. 2 and 3). The 
present study demonstrates significant levels of BNP tran- 
TABLE 1. Expression of BNP and ANP in various human tissues 
Subject A Subject B 
BNP cDNA/total ANP cDNA/total 
cDNA (% x 10-Y cDNA (% x 10d) 
BNP cDNA/total ANP CDNA/total 
cDNA (% x 10”) cDNA (W x lo+) 
Left ventricule 23 20 
CNS 2.34 1.02 
Pituitary 
Thyroid 
Lung 
Kidney 
Adrenal gland 
Liver 
Pancreas 
Spleen 
Small intestine 
Prostate 
Testis 
Ovarv 
1.15 Undet. 
2.25 1.05 
2.01 2.33 
0.48 3.80 
0.75 0.38 
Undet. Undet. 
Undet. ND 
0.83 1.50 
ND ND 
16.79 6.70 
595 
0.82 
1.34 
ND 
0.34 
0.34 
0.68 
Undet. 
ND 
0.59 
0.69 
0.35 
2.92 
ii 
ND 
ND 
0.15 
0.29 
ND 
Undet. 
ND 
ND 
0.22 
ND 
Undet. 
Uterus 1.56 
Striated muscle ND 
Undet., Undetected; ND, not determined. 
3.34 
ND 0.71 0.65 
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TABLE 2. Expression of BNP in various human tissues (BNP 
cDNA/total cDNA (% x lo-? 
Ventricle 
Pituitary 
Lung 
Liver 
Pancreas 
Ovary 
Undet., Undetected. 
Subject C Subject A 
45 23 
1.73 1.15 
0.41 2.01 
Undet. Undet. 
Undet. Undet. 
0.86 16.79 
scription in extracardiac human tissues. Indeed, whereas the 
level of BNP transcription in control, nondiseased human 
ventricle was almost identical to the level of BNP transcripts 
detected by the same PCR approach in rat ventricles (22), 
the level of BNP transcripts in extracardiac human tissues 
was generally 1 and often 2 orders of magnitude higher than 
the level detected in rat extracardiac tissues. For example, in 
rat, the abundance of BNP mRNA in brain or lung was lOOO- 
fold lower than in ventricles whereas in human tissues of 
two subjects (with no history of cardiovascular disorders) 
brain and lung BNP mRNA levels were only lo- to 20-fold 
lower than in ventricles. 
The finding that several endocrine organs contain appre- 
ciable levels of BNP mRNA raises the possibility that extra- 
cardiac tissues might contribute to circulating BNP levels in 
human. The contribution of extracardiac tissues to plasma 
BNP was raised by Mukoyama et al. (25) as a possible 
explanation for the differential clearance of ANP and BNP 
from the circulation. The presence of BNP transcripts does 
not prove that the peptide will also be synthesized. However, 
so far there is no evidence for translational control of either 
BNP or ANP, and the presence of BNP and ANP transcripts 
and their regulation has been generally paralleled by similar 
regulation at the peptide.level (1, 22, 25). The finding of 
ANP transcripts in central and peripheral organs is in agree- 
ment with the demonstration of ANP mRNA in several 
extracardiac tissues of other species like mouse, rat, or 
chicken (2, 3) and therefore suggests a conserved tissue 
distribution of ANP across species. Interestingly, the ratio of 
BNP to ANP in brain and adrenal was 2:l which is in perfect 
agreement with the reported ratio of BNP to ANP peptide in 
porcine brain (32) and bovine adrenal (33). 
The presence of both ANP and BNP transcripts in repro- 
ductive organs is noteworthy. ANP precursor has previously 
been detected in rat testis (13) and ovaries (34), together with 
specific ANP/BNP receptors in these tissues (34). The finding 
that the BNP gene is also transcribed in ovaries merits further 
investigation particularly in view of the dramatically elevated 
levels of BNP in normal tissue of the ovaries of subject A 
who had an ovarian carcinoma relative to BNP levels in 
intact ovaries. Indeed, as shown in Table 2, BNP mRNA 
levels were either similar or 2-fold higher in ventricles, 
pituitary, and lung of subject A whereas ovarian BNP mRNA 
were 20-fold increased, and reached levels comparable to 
ventricles. 
Finally, both ANP and particularly BNP transcripts were 
markedly elevated in the ventricles of subject B who had 
cardiac hypertrophy. This is in agreement with reports show- 
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ing greater induction of BNP than ANP in pathophysiological 
conditions of the heart (25, 30). Interestingly, extracardiac 
ANP and BNP levels were not increased concomitantly with 
increased ventricular BNP and ANP. Furthermore the ratio 
of BNP to ANP transcripts was variable in the different 
tissues examined. Thus, our data argue for a differential 
tissue-specific regulation of the BNP gene. Together with the 
differential tissue distribution of various natriuretic peptide 
receptors (35), our findings underscore the diversity of the 
dual ANP/BNP natriuretic peptide system and could further 
stimulate the investigation of their functional importance in 
peripheral tissues. 
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